Immunohematology Market's Surge Amidst Hematological Disorders: Strengthening the Growth Trajectory of the Immunohematology Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Immunohematology Market Through 2025?
The dimension of the immunohematology market has been consistently expanding in recent years. The market value is projected to increase from $2.46 billion in 2024 to $2.55 billion in 2025 with a compound annual growth rate (CAGR) of 3.6%. Factors contributing to the growth during the historical period include enhancements in blood transfusion technology, widespread blood disorders, growth of blood banks, governmental measures for blood safety, a rise in surgical procedures, and heightened awareness about the risks related to transfusion.

What's the Projected Size of the Global Immunohematology Market by 2029?
In the coming years, the immunohematology market is predicted to experience robust growth. The market value is anticipated to reach $3.17 billion in 2029, with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to the growth during this forecast period include the rising demand for point-of-care testing, the advent of innovative blood products, healthcare infrastructure expansion, blood compatibility genetic testing, and regulatory support for blood safety. The forecast period also sees significant trends such as automation and high-throughput systems, molecular methods of blood typing, techniques for antibody detection, patient blood management programs, integration of artificial intelligence in analysis, and the incorporation of telemedicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Top Growth Drivers in the Immunohematology Industry: What's Accelerating the Market?
The immunohematology market is predicted to expand due to the increasing occurrence of hematological disorders. These disorders encompass a varied range of conditions that impact the components of blood, including red and white blood cells, platelets, and plasma. Immunohematology plays a significant role in ensuring efficient and uncomplicated blood transfusions, preventing transfusion reactions due to clashing blood types or antibodies in the receiver's blood. The techniques of immunohematology are crucial in diagnosing and treating diseases related to the immune system that can influence the hematological system. As per data from Cancer Research UK, a research institute located in the UK, the average number of fresh leukemia cases resulting from hematological disorders in the UK is anticipated to increase from approximately 12,400 cases during 2023-2025 to about 14,500 cases during 2038-2040. Hence, the escalation in hematological disorders is spurring the growth of the immunohematology market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Trends Will Shape the Immunohematology Market Through 2029 and Beyond?
Leading businesses in the immunohematology market are centered on creating groundbreaking diagnostic options, such as the soluble recombinant proteins designed specifically to surmount the interference brought by daratumumab, a cancer treatment. Soluble recombinant protein, a protein birthed from recombinant DNA technology, maintains its functional and proper form either in a host cell or a solution, making it ideal for research and therapeutic uses. For instance, in November 2023, Grifols, S.A., a pharmaceutical entity hailing from Spain, launched Grifols sCD38 solution, marking the first soluble recombinant protein in existence. Crafted to tackle interference from daratumumab in crucial blood transfusion compatibility tests, this innovative solution is tailor-made for patients of multiple myeloma. Grifols' sCD38 hinders daratumumab from binding with CD38 proteins located on red blood cells, ensuring accurate pre-transfusion test results. The introduction of Grifols sCD38 makes the process of screening, identification, and crossmatching smoother, and consequently streamlines blood transfusion protocols while reducing delays in providing lifesaving transfusions.

What Are the Main Segments in the Immunohematology Market?
The immunohematology market covered in this report is segmented -

1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:
1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

Which Top Companies are Driving Growth in the Immunohematology Market?
Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Which Regions Will Dominate the Immunohematology Market Through 2029?
North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.